Safety evaluation of overdose intake of foods containing Lactobacillus brevis subsp. coagulans (Labre) - Safety evaluation of overdose intake of foods containing Lactobacillus brevis subsp. coagulans (Labre)

Medical Corporation Hokubukai Utsukushigaoka Hospital0 个研究点目标入组 20 人开始时间: 2023年11月8日最近更新: 2023年11月20日

试验速览

暂无简介。

•(1) Subjects who have a history of heart, liver, kidney disease, organ damage, diabetes, or other serious diseases (2) Subjects who have a history of gastrointestinal surgery (excluding appendectomy) (3) Subjects who are currently receiving medical drug treatment (4) Subjects who are pregnant, wish to become pregnant during the study, or are breastfeeding (5) Subjects who take foods or supplements containing lactobacilli or bifidobacteria 3 times or more a week (Suguki pickle, bran pickle, kimchi, "Labre capsules", etc.) (6) Shift workers, including late-night shifts (7) Subjects who drink more than 60 g pure alcohol equivalent/day on average (8) Subjects who smoke an average of 21 cigarettes or more per day (9) Subjects who donated blood within 3 months at screening (10) Subjects who are participating in clinical research or monitoring (food, pharmaceuticals, cosmetics) other than this research, or plan to participate during this research period (11) Subjects who are judged to be inappropriate for this study with other reasons by the principal investigator.

发起方

Medical Corporation Hokubukai Utsukushigaoka Hospital